1. Home
  2. ROMA vs MIRA Comparison

ROMA vs MIRA Comparison

Compare ROMA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roma Green Finance Limited

ROMA

Roma Green Finance Limited

N/A

Current Price

$8.70

Market Cap

558.1M

Sector

Finance

ML Signal

N/A

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

N/A

Current Price

$0.72

Market Cap

32.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROMA
MIRA
Founded
2018
2020
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
558.1M
32.1M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
ROMA
MIRA
Price
$8.70
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1K
★ 172.8K
Earning Date
07-31-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.16
$0.60
52 Week High
$11.77
$2.45

Technical Indicators

Market Signals
Indicator
ROMA
MIRA
Relative Strength Index (RSI) 43.54 52.40
Support Level $8.15 $0.72
Resistance Level $8.68 $1.02
Average True Range (ATR) 0.28 0.05
MACD -0.07 0.01
Stochastic Oscillator 9.77 56.48

Price Performance

Historical Comparison
ROMA
MIRA

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is a professional specialist in the provision of environmental, social and governance (ESG), sustainability and climate change related advisory services through its operating subsidiaries in Hong Kong and Singapore. Its services include Sustainability Program Development, ESG Reporting, Corporate Governance and Risk Management, Climate Change Strategies and Solutions, Environmental Audit, ESG Rating Support and Shareholder Communication, and Education and Training. It operates in one reporting business segment in Hong Kong and Singapore, of which the majority of revenue is derived from Hong Kong.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: